Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03175757 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels
A NA study, sponsored by Supplement Formulators.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03175757: Completed NA study, sponsored by Supplement Formulators.
NCT03175757 is a NA study that has completed, run by Supplement Formulators. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03175757, a NA study, has completed, sponsored by Supplement Formulators.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects of a turmeric and black cumin seed formulation on cholesterol levels.
Primary Outcome
Mean change from Baseline/screening to Day 60
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Turmeric and Black Cumin Seed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-05-12 |
| Est. Completion | 2018-08-16 |
| Phase | NA |
What the finished NCT03175757 record still lists
NCT03175757 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03175757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03175757 about?
NCT03175757 is a clinical study titled "A Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels". The purpose of this study is to assess the effects of a turmeric and black cumin seed formulation on cholesterol levels.
What is the current status of trial NCT03175757?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2017-05-12. Estimated completion is 2018-08-16.
What interventions are being tested in trial NCT03175757?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Turmeric and Black Cumin Seed (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03175757?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03175757's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI